Importance of ovarian tissue cryopreservation in fertility preservation and anti-aging treatment

References

• Martinez F, Andersen CY, Barri PN, International Society for Fertility Preservation–ESHRE–ASRM Expert Working Group, et al. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril. 2017;108:407–415.
   PubMed Web of Science ®Google Scholar
• Kasum M, Beketić-Orešković L, Peddi PF, et al. Fertility after breast cancer treatment. Eur J Obstet Gynecol Reprod Biol. 2014;173:13–18.
   PubMed Web of Science ®Google Scholar
• Chae-Kim JJ, Gavrilova-Jordan L. Premature ovarian insufficiency: procreative management and preventive strategies. Biomedicines. 2018;7:2.
   Web of Science ®Google Scholar
• Faubion SS, Kuhle CL, Shuster LT, et al. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18:483–491.
   PubMed Web of Science ®Google Scholar
• Kristensen SG, Andersen CY. Cryopreservation of ovarian tissue: opportunities beyond fertility preservation and a positive view into the future. Front Endocrinol (Lausanne). 2018;9:347.
   Web of Science ®Google Scholar
• Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. JCO. 2018;36:1994–2001.
   PubMed Web of Science ®Google Scholar
• Paluch-Shimon S, Pagani O, Partridge AH, et al. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). Breast. 2017;35:203–217.
   PubMed Web of Science ®Google Scholar
• Lee S, Ozkavukcu S, Heytens E, et al. Value of early referral to fertility preservation in young women with breast cancer. JCO. 2010;28:4683–4686.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Wallace WHB, Telfer EE. Ovarian tissue cryopreservation for fertility preservation: clinical and research perspectives. Hum Reprod Open. 2017;1:1–9.
   Google Scholar
• Lobo RA, Davis SR, De Villiers TJ, et al. Prevention of diseases after menopause. Climacteric. 2014;17:540–556.
   PubMed Web of Science ®Google Scholar
• Lobo RA. Hormone-replacement therapy: current thinking. Nat Rev Endocrinol. 2017;13:220–231.
   PubMed Web of Science ®Google Scholar
• Lobo RA. What the future holds for women after menopause: where we have been, where we are, and where we want to go. Climacteric. 2014;17:12–17.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. Natural hormone replacement therapy with a functioning ovary after the menopause: dream or reality? Reprod Biomed Online. 2018;37:359–366.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Fauser B. Ovarian tissue transplantation for hormone replacement. Reprod Biomed Online. 2018;37:251–252.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017;377:1657–1665.
   PubMed Web of Science ®Google Scholar
• Dolmans MM, Manavella DD. Recent advances in fertility preservation. J Obstet Gynaecol Res. 2019;45:266–279.
   PubMed Web of Science ®Google Scholar
• Smith GD, Serafini PC, Fioravanti J, et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil Steril. 2010;94:2088–2095.
   PubMed Web of Science ®Google Scholar
• Amorim CA, Curaba M, Van Langendonckt A, et al. Vitrification as an alternative means of cryopreserving ovarian tissue. Reprod Biomed Online. 2011;23:160–186.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Yoshioka N, Takae S, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30:608–615.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee Y, Lee S, et al. Ovarian tissue cryopreservation and transplantation in patients with cancer. Obstet Gynecol Sci. 2018;61:431–442.
   PubMedGoogle Scholar
• Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet. 2015;32:1167–1170.
   PubMed Web of Science ®Google Scholar
• Stern CJ, Gook D, Hale LG, et al. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. Hum Reprod. 2013;28:2996–2999.
   PubMed Web of Science ®Google Scholar
• Pacheco F, Oktay K. Current success and efficiency of autologous ovarian transplantation: a meta-analysis. Reprod Sci. 2017;24:1111–1120.
   PubMed Web of Science ®Google Scholar
• Medrano JV, Andrés MDM, García S, et al. Basic and clinical approaches for fertility preservation and restoration in cancer patients. Trends Biotechnol. 2018;36:199–215.
   PubMed Web of Science ®Google Scholar
• Gavish Z, Spector I, Peer G, et al. Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation. J Assist Reprod Genet. 2018;35:61–69.
   PubMed Web of Science ®Google Scholar
• Gavish Z, Peer G, Hadassa R, et al. Follicle activation and 'burn-out' contribute to post-transplantation follicle loss in ovarian tissue grafts: the effect of graft thickness. Hum Reprod. 2014;29:989–996.
   PubMed Web of Science ®Google Scholar
• Kim SS. Time to re-think: ovarian tissue transplantation versus whole ovary transplantation. Reprod Biomed Online. 2010;20:171–174.
   PubMed Web of Science ®Google Scholar
• Taylan E, Oktay K. Autologous transplantation of human ovarian tissue. In: Leung PCK, Adashi EY, editors. The ovary (3rd ed.). London: Academic Press; 2019. p.493–500.
   Google Scholar
• Fisch B, Abir R. Female fertility preservation: past, present and future. Reproduction. 2018;156:F11–F27.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Wallberg KA, Oktay K. Fertility preservation during cancer treatment: clinical guidelines. Cancer Manag Res. 2014;6:105–117.
   PubMed Web of Science ®Google Scholar
• Dolmans MM, Masciangelo R. Risk of transplanting malignant cells in cryopreserved ovarian tissue. Minerva Ginecol. 2018;70:436–443.
   PubMed Web of Science ®Google Scholar
• Shapira M, Raanani H, Barshack I, et al. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Fertil Steril. 2018;109:48–53.
   PubMed Web of Science ®Google Scholar
• Chiti MC, Donnez J, Amorim CA, et al. From isolation of human ovarian follicles to the artificial ovary: tips and tricks. Minerva Ginecol. 2018;70:444–455.
   PubMed Web of Science ®Google Scholar
• Dath C, Dethy A, Van Langendonckt A, et al. Endothelial cells are essential for ovarian stromal tissue restructuring after xenotransplantation of isolated ovarian stromal cells. Hum Reprod. 2011;26:1431–1439.
   PubMed Web of Science ®Google Scholar
• Stoop D, van der Veen F, Deneyer M, et al. Oocyte banking for anticipated gamete exhaustion (AGE) is a preventive intervention, neither social nor nonmedical. Reprod Biomed Online. 2014;28:548–551.
   PubMed Web of Science ®Google Scholar
• Stoop D, Cobo A, Silber S. Fertility preservation for age-related fertility decline. Lancet. 2014;384:1311–1319.
   PubMed Web of Science ®Google Scholar
• Yasui T, Hayashi K, Mizunuma H, et al. Factors associated with premature ovarian failure, early menopause and earlier onset of menopause in Japanese women. Maturitas. 2012;72:249–255.
   PubMed Web of Science ®Google Scholar
• Bjelland EK, Wilkosz P, Tanbo TG, et al. Is unilateral oophorectomy associated with age at menopause? A population study (the HUNT2 Survey). Hum Reprod. 2014;29:835–841.
   PubMed Web of Science ®Google Scholar
• Rosendahl M, Simonsen MK, Kjer JJ. The influence of unilateral oophorectomy on the age of menopause. Climacteric. 2017;20:540–544.
   PubMed Web of Science ®Google Scholar
• Sjögren LL, Mørch LS, Løkkegaard E. Hormone replacement therapy and the risk of endometrial cancer: a systematic review. Maturitas. 2016;91:25–35.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333.
   PubMed Web of Science ®Google Scholar
• Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107:103–111.
   PubMed Web of Science ®Google Scholar
• Collaborative Group On Epidemiological Studies Of Ovarian Cancer, Beral V, Gaitskell K, Hermon C, et al. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet. 2015;385:1835–1842.
   PubMed Web of Science ®Google Scholar
• Sweetland S, Beral V, Balkwill A, et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost. 2012;10:2277–2286.
   PubMed Web of Science ®Google Scholar
• Bergendal A, Kieler H, Sundström A, et al. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration. Menopause. 2016;23:593–599.
   PubMed Web of Science ®Google Scholar
• Sittadjody S, Saul JM, McQuilling JP, et al. In vivo transplantation of 3D encapsulated ovarian constructs in rats corrects abnormalities of ovarian failure. Nat Commun. 2017;8:1858.
   PubMed Web of Science ®Google Scholar
• Oktay K, Economos K, Kan M, et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA. 2001;286:1490–1493.
   PubMed Web of Science ®Google Scholar
• Schmidt KL, Andersen CY, Loft A, et al. Follow up of ovarian function post chemotherapy following ovarian cryopreservation and transplantation. Hum Reprod. 2005;20:3539–3546.
   PubMed Web of Science ®Google Scholar
• Kim SS. Assessment of long term endocrine function after transplantation of frozen–thawed human ovarian tissue to the heterotopic site: 10 year longitudinal follow-up study. J Assist Reprod Genet. 2012;29:489–493.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99:1503–1513.
   PubMed Web of Science ®Google Scholar
• Silber SJ, DeRosa M, Goldsmith S, et al. Cryopreservation and transplantation of ovarian tissue: results from one center in the USA. J Assist Reprod Genet. 2018;35:2205–2213.
   PubMed Web of Science ®Google Scholar
• Jensen AK, Kristensen SG, Macklon KT, et al. Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark. Hum Reprod. 2015;30:2838–2845.
   PubMed Web of Science ®Google Scholar
• Kim SS, Lee WS, Chung MK, et al. Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients. Fertil Steril. 2009;91:2349–2354.
   PubMed Web of Science ®Google Scholar
• Shifren JL, Davis SR. Androgens in postmenopausal women: a review. Menopause. 2017;24:970–979.
   PubMed Web of Science ®Google Scholar
• Simon JA, Goldstein I, Kim NN, et al. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review. Menopause. 2018;25:837–847.
   PubMed Web of Science ®Google Scholar
• Kim SS. Revisiting the role of heterotopic ovarian transplantation: futility or fertility. Reprod Biomed Online. 2014;28:141–145.
   PubMed Web of Science ®Google Scholar
• von Wolff M, Stute P. Cryopreservation and transplantation of ovarian tissue exclusively to postpone menopause: technically possible but endocrinologically doubtful. Reprod Biomed Online. 2015;31:718–721.
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Anderson GL, Sarto GE, et al. Continuous combined estrogen plus progestin and endometrial cancer: the women's health initiative randomized trial. JNCIJ. 2016;108:dvj350.
   Google Scholar
• Patrizio P, Caplan AL. Forever young? The ethical challenges of using ovarian tissue transplants to treat menopause. Reprod Biomed Online. 2015;31:132–133.
   PubMed Web of Science ®Google Scholar